UC Irvine Global Health Researcher Receives $4.3 Million to Study Invasive Malaria Vector and Urban Malaria in Africa

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.uci.edu/2024/05/14/uc-irvine-global-health-researcher-receives-4-3-million-to-study-invasive-malaria-vector-and-urban-malaria-in-africa/
Research Institution
University of California, Irvine
Short Title
UC Irvine Global Health Researcher Receives $4.3 Million to Study Invasive Malaria Vector and Urban Malaria in Africa
Content Coordinator
Claudia Wair

Injectable HIV Medication is Superior to Oral Medication for Patients Who Frequently Miss Doses, Study Finds

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://news.cuanschutz.edu/department-of-medicine/research-injectable-hiv-medication-patients
Research Institution
University of Colorado Department of Medicine
Short Title
Injectable HIV Medication is Superior to Oral Medication for Patients Who Frequently Miss Doses, Study Finds
Content Coordinator
Claudia Wair

A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans

UNC School of Medicine Leads $9.3-Million Study to Create Chlamydia Vaccine

How the “Home” Environment Influences Microbial Interactions

Penn Researchers Develop Experimental mRNA Avian Flu Vaccine

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.pennmedicine.org/news/news-releases/2024/may/penn-researchers-develop-experimental-mrna-avian-flu-vaccine
Research Institution
University of Pennsylvania Perelman School of Medicine
Short Title
Penn Researchers Develop Experimental mRNA Avian Flu Vaccine
Content Coordinator
Claudia Wair

How COVID-19 “Breakthrough” Infections Alter Your Immune Cells

New Antibiotic Kills Pathogenic Bacteria, Spares Healthy Gut Microbes

ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.atcc.org/about-us/newsroom/2024-news-releases/atcc-announces-award-from-niaid-to-provide-antiviral-screening-assays-relevant-to-human-diseases
Research Institution
ATCC
Short Title
ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Dis
Content Coordinator
Claudia Wair

Infectious H5N1 Influenza Virus in Raw Milk Rapidly Declines with Heat Treatment

The amount of infectious H5N1 influenza viruses in raw milk rapidly declined with heat treatment in laboratory research conducted by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. However, small, detectable amounts of infectious virus remained in raw milk samples with high virus levels when treated at 72 degrees Celsius (161.6 degrees Fahrenheit) for 15 seconds—one of the standard pasteurization methods used by the dairy industry.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Subscribe to Emerging Infectious Diseases/Pathogens